Scientific Programme
![]() |
12:45 - 14:15 Poster Session 3 - Male incontinence
| 65: Changes of urodynamic findings and lower urinary tract symptoms after radical prostatectomy T. Mitsui, Sapporo (JP) |
| 66: Transurethral ultrasound guided injection of autologus myo- and fibroblasts in incontinent men: 2 year data H. Strasser, Innsbruck (AT) |
| 67: Repair of iatrogenic sphincter damage and urinary incontinence by autologous skeletal muscle derived cells (MDC) H. Gerullis, Neus (DE) |
| 68: AdVance? male sling: Anatomic evidence of retrourethral position after tensioning without direct urethral compression P. Rehder, Innsbruck (AT) |
| 69: The AdVance male sling system: A new treatment option to improve male stress urinary incontinence significantly B. Amend, Tübingen (DE) |
| 70: ARGUS® a new adjustable sling in the low invasive treatment of post prostatectomy incontinence H. Gallistl, Korneuburg (AT) |
| 71: The use of invance, the male sling system, in patients with stress urinary incontinence (SUI) post radical prostatectomy (RP): 2 year follow-up M. Brausi, Carpi ( Modena ) (IT) |
| 72: Radical prostatectomy (RP) and sphincter damage? What can we learn from pitfalls ? C. Eimer, Neuss (DE) |
| 73: Patient perceived outcome and objective success rate in the treatment of post prostatectomy incontinence (PPI) after a long term follow-up: Results of three different surgical approaches E.R. Huber, Vienna (AT) |
| 74: Adjustable continence therapy for the treatment of male urodynamic stress urinary incontinence ? single centre study E. Kocjancic, Udine (IT) |
| 75: International multicentre evaluation of the adjustable continence therapy (ProACT?) for male post prostatectomy stress urinary incontinence P.J. Gilling, Tauranga (NZ) |
| 76: Transrectal ultrasound-guided implantation of the ProACT system in patients with post-radical prostatectomy stress urinary incontinence: Preliminary clinical results of a prospective study A. Gregori, Milan (IT) |
| 77: Lower urinary tract symptoms after artificial urinary sphincter placement? the patients? perspective M. Belal, London (GB) |



